| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |